➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

Patent: 5,571,839

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,571,839
Title: D-aspartic acid .beta.-hydroxamate for the treatment of viral infections and tumors
Abstract:Beta-hydroxamate D-aspartic acid as a medicine, in particular for treating infectious diseases caused by retroviruses, especially those that cause AIDS, as well as for treating tumors.
Inventor(s): Vila; Jorge (Irigny, FR), Thomasset; Nicole (Villeurbanne, FR), Hamedi Sangsari; Farid (Lyons, FR), Grange; Jacques (Oullins, FR)
Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM) (Paris, FR)
Application Number:08/034,399
Patent Claims:see list of patent claims

Details for Patent 5,571,839

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Institut National de la Sante et de la Recherche Medicale (INSERM) (Paris, FR) 2013-11-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 5,571,839

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.